Google Inc. (GOOG): Search Market Share Drops in Latest Report

Page 1 of 2

Google Inc. (NASDAQ:GOOG) made a name for itself with Google Search, so one might worry when the dominant web search engine of the last 15 years loses market share.

There is panic! Ummm, yeah. Panic. Riiiight.

Maybe it would be one thing if the loss was significant and a single competitor gained all the loss, but that is not the case. However, it is a little noteworthy that as the number of web searches recorded in the latest survey by comScore could indicate that Google may actually be slipping a bit in its dominance.

Google Inc (NASDAQ:GOOG)

In the latest one-month survey of web searches conducted from November 12 to December 12 of 2012, Google Inc. (NASDAQ:GOOG)recorded 66.7 percent of the market, which is actually a 0.3 percent drop from the previous survey. The top competitors, Bing by Microsoft Corporation (NASDAQ:MSFT) added 0.1 percent to 16.3 percent, while Yahoo! Inc. (NASDAQ:YHOO) is third with 12.2 percent. The key item is that the entire 0.3 percent loss by Google did not go to any one competitor; each of the next three competitors increased their share by 0.1 percent each.

In this most recent survey, there were 17.6 billion Web searches worldwide, up 4 percent from the previous month. Google Inc. (NASDAQ:GOOG) searches were also up 4 percent to 11.7 billion, while Microsoft Corporation (NASDAQ:MSFT) Bing searches were up 5 percent to 2.8 billion. However, the gulf between Google and Bing may actually be smaller when one considers that some of the searches are “powered by” other competitors.

When comScore looks at the search engine that “powers” all searches and not just the name on the front of the search page, it seems that Google Inc. (NASDAQ:GOOG) may have some room at least for concern, if not the outright panic.

What kind of concern, you might ask?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!